Capital International Investors Buys 800,000 Shares of Rapport Therapeutics, Inc. $RAPP

Capital International Investors grew its position in shares of Rapport Therapeutics, Inc. (NASDAQ: RAPP) by 30.7% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,402,529 shares of the company's stock after purchasing an additional 800,000 shares during the quarter. Capital International